Roundup Residue Found in Popular German Beers

Amid continuing concerns about the potential risk of cancer from the Roundup weedkiller active ingredient, glyphosate, a recent study found traces of the chemical in fourteen of Germany’s most popular brands of beers, highlighting the widespread use of the herbicide.

The Munich Environmental Institute, a German environmental group, issued a press release (in German) announcing the test results on February 25, which showed that all of the country’s most popular brands of beer contained levelsย higher than 0.1 microgram of glyphosate, the amount legally allowed in drinking water in that country.

The findings are particularly noteworthy in Germany, due to its 500-year-old “Reinheitsgebot” beer purity law, which requires that beers only be produced using hops, malt, water and yeast.

Roundup-Cancer-Lawsuit-Lawyer
Roundup-Cancer-Lawsuit-Lawyer

The potential health risks of Roundup and glyphosate have been the subject of increasing concerns worldwide, since the World Health Organization determined that glyphosate probably causes cancer in humans in March 2015.

The use of glyphosate has skyrocketed in recent years, amid Monsantoโ€™s marketing strategy of creating โ€œRoundup Readyโ€ genetically modified seeds for crops, which are designed to withstand heavy use of the herbicide, but have resulted in more and more of the herbicide being sprayed on farm lands.

To date, about 18.9 billion pounds of glyphosate have been sprayed on the worldโ€™s crops, according to estimates of a recentย study. Researchers found thatย glyphosate use has increased almost 15-fold since the introduction of โ€œRoundup Readyโ€ crops in 1996.

Over the past year, Monsanto has been attempting to defend the safety of Roundup, dismissing concerns about their blockbuster product and suggesting that the WRO’s conclusions were agenda driven and based on “junk science”.

The Munich Environmental Institute’s recent report has come under fire by the German Brauer-Bund beer association, which said the sampling method the group used was unreliable. In addition, the German Federal Institute for Risk said that the amounts detected did not constitute a risk to human health.

Officials with the environmental group criticized those viewpoints, noting that if the IARC is correct, even minute amounts of glyphosate could cause harm and that there could be no safe amount of daily glyphosate intake.

The report came just days after the FDA in the U.S. announced that it would begin monitoring glyphosate residue in certain foods, which it has never done before.

Monsanto now faces a growing number of Roundup cancer lawsuits in the United States, typically involving individuals diagnosed with a form of non-Hodgkin’s lymphoma following heavy exposure to the herbicide as a farm or agricultural worker. In addition, a growing number of states, cities, and countries worldwide have enacted full or partial glyphosate bans to protect citizens and limit the risks of Roundup exposure.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

In a joint statement, plaintiffs and defendants in AngioDynamics port catheter lawsuits have laid guidelines for what types of cases should be selected to serve as potential bellwether trials.
Women who experienced infection, chronic inflammation, implant instability or other complications after internal bra mesh procedures are now questioning whether those risks were fully disclosed before implantation.
More than 3,300 women have filed Depo-Provera lawsuits in federal court, with several hundred more also pending in state courts in New York and Delaware, according to a recent status report.